Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study.

IF 2.5 3区医学 Q1 ORTHOPEDICS

Journal of Foot and Ankle Research Pub Date : 2023-08-21 DOI:10.1186/s13047-023-00650-y

Raquel Veiga-Seijo, Sonia Pertega-Diaz, Maria Eva Perez-Lopez, Lourdes Calvo Martinez, Silvia Antolin Novoa, Cristina Gonzalez-Martin

{"title":"Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study.","authors":"Raquel Veiga-Seijo, Sonia Pertega-Diaz, Maria Eva Perez-Lopez, Lourdes Calvo Martinez, Silvia Antolin Novoa, Cristina Gonzalez-Martin","doi":"10.1186/s13047-023-00650-y","DOIUrl":null,"url":null,"abstract":"Background: Chemotherapy is one of the most widely used therapies for breast cancer, triggering important repercussions on people's quality of life. However, little research has been undertaken about podiatric adverse effects. This study aimed was to determine the prevalence of podiatric pathology developed in people with breast cancer who receive chemotherapy.Methods: Observational, descriptive, and cross-sectional study was conducted in the Oncology service of the A Coruña University Hospital (northwest Spain). People with breast cancer and undergoing chemotherapy treatment of legal age (≥ 18), who signed the informed consent (n = 117) were included. Sociodemographic, comorbidity, disease and foot health variables, as well as two self-administered questionnaires (Foot Health Status Questionnaire and Foot Function Index) were studied. The current ethical-legal aspects were followed.Results: Foot health problems were highly prevalent, highlighting nail color changes (59.8%), onychocryptosis (39.7%), xerosis (62.4%), plantar fasciitis (12.8%), and neuropathic symptoms (75.2%). Some foot pain was presented in 77.8% of the sample, predominantly at nail level (15.4%) or sole of the foot and nail (14.5%). Most participants described their foot health as fair or poor (56.4%) and felt limited in walking (65.8%). The lowest score for the Foot Health Status Questionnaire was footwear (30.6(33.5)).Conclusions: Foot health adverse effects represent worrisome problems in women with breast cancer undergoing chemotherapy, due to their high prevalence and negative implications on quality of life. These problems are critical as they may have implications for stopping or reducing chemotherapy. All these results call for the development of more research to contribute to the care and wellbeing of people with cancer who receive treatments such as chemotherapy. Thus, this line of research is a new path to be developed by the podiatry community.","PeriodicalId":49164,"journal":{"name":"Journal of Foot and Ankle Research","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440865/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Foot and Ankle Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13047-023-00650-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Chemotherapy is one of the most widely used therapies for breast cancer, triggering important repercussions on people's quality of life. However, little research has been undertaken about podiatric adverse effects. This study aimed was to determine the prevalence of podiatric pathology developed in people with breast cancer who receive chemotherapy.

Methods: Observational, descriptive, and cross-sectional study was conducted in the Oncology service of the A Coruña University Hospital (northwest Spain). People with breast cancer and undergoing chemotherapy treatment of legal age (≥ 18), who signed the informed consent (n = 117) were included. Sociodemographic, comorbidity, disease and foot health variables, as well as two self-administered questionnaires (Foot Health Status Questionnaire and Foot Function Index) were studied. The current ethical-legal aspects were followed.

Results: Foot health problems were highly prevalent, highlighting nail color changes (59.8%), onychocryptosis (39.7%), xerosis (62.4%), plantar fasciitis (12.8%), and neuropathic symptoms (75.2%). Some foot pain was presented in 77.8% of the sample, predominantly at nail level (15.4%) or sole of the foot and nail (14.5%). Most participants described their foot health as fair or poor (56.4%) and felt limited in walking (65.8%). The lowest score for the Foot Health Status Questionnaire was footwear (30.6(33.5)).

Conclusions: Foot health adverse effects represent worrisome problems in women with breast cancer undergoing chemotherapy, due to their high prevalence and negative implications on quality of life. These problems are critical as they may have implications for stopping or reducing chemotherapy. All these results call for the development of more research to contribute to the care and wellbeing of people with cancer who receive treatments such as chemotherapy. Thus, this line of research is a new path to be developed by the podiatry community.

查看原文本刊更多论文

接受化疗的乳腺癌患者足部健康和生活质量:一项横断面研究

背景:化疗是乳腺癌最广泛使用的治疗方法之一，对人们的生活质量产生重要影响。然而，关于足部不良反应的研究很少。本研究旨在确定接受化疗的乳腺癌患者足部病变的患病率。方法:在A Coruña大学医院(西班牙西北部)肿瘤科进行观察性、描述性和横断面研究。纳入签署知情同意书的法定年龄(≥18岁)乳腺癌患者和正在接受化疗的患者(n = 117)。研究了社会人口学、合并症、疾病和足部健康变量，以及两份自填问卷(足部健康状况问卷和足部功能指数)。遵循了当前的伦理-法律方面。结果:足部健康问题非常普遍，突出指甲颜色改变(59.8%)，趾甲隐匿(39.7%)，干燥(62.4%)，足底筋膜炎(12.8%)和神经病变症状(75.2%)。77.8%的样本出现足部疼痛，主要在指甲水平(15.4%)或足底和指甲(14.5%)。大多数参与者将自己的足部健康状况描述为一般或较差(56.4%)，并感到行走受限(65.8%)。足部健康状况问卷得分最低的是鞋类(30.6(33.5))。结论:在接受化疗的乳腺癌患者中，足部健康不良反应是令人担忧的问题，因为它们的高患病率和对生活质量的负面影响。这些问题至关重要，因为它们可能会影响停止或减少化疗。所有这些结果都要求开展更多的研究，为接受化疗等治疗的癌症患者的护理和福祉做出贡献。因此，这条研究路线是足病界发展的新途径。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Foot and Ankle Research ORTHOPEDICS-

CiteScore

4.50

自引率

10.30%

发文量

审稿时长

>12 weeks

期刊介绍： Journal of Foot and Ankle Research, the official journal of the Australian Podiatry Association and The College of Podiatry (UK), is an open access journal that encompasses all aspects of policy, organisation, delivery and clinical practice related to the assessment, diagnosis, prevention and management of foot and ankle disorders. Journal of Foot and Ankle Research covers a wide range of clinical subject areas, including diabetology, paediatrics, sports medicine, gerontology and geriatrics, foot surgery, physical therapy, dermatology, wound management, radiology, biomechanics and bioengineering, orthotics and prosthetics, as well the broad areas of epidemiology, policy, organisation and delivery of services related to foot and ankle care. The journal encourages submissions from all health professionals who manage lower limb conditions, including podiatrists, nurses, physical therapists and physiotherapists, orthopaedists, manual therapists, medical specialists and general medical practitioners, as well as health service researchers concerned with foot and ankle care. The Australian Podiatry Association and the College of Podiatry (UK) have reserve funds to cover the article-processing charge for manuscripts submitted by its members. Society members can email the appropriate contact at Australian Podiatry Association or The College of Podiatry to obtain the corresponding code to enter on submission.

文献相关原料

公司名称	产品信息	采购帮参考价格